Clinical Development

Virtually test thousands of clinical hypotheses in minutes to improve and optimize your clinical trial protocols. 

 

Get Started
1734870531-clinical-development (1) 1735223878-clinical-development-mobile (1)

Protocol Design & Optimization

Find the optimal trial design before you commit to one.
Clinical Development teams can now adjust any protocol parameter and instantly see how that change affects clinical outcomes, feasibility, cost, and commercial impact. The platform is highly adaptable, allowing for granular modifications to treatment arms, comparators, outcomes, endpoints, inclusion/exclusion criteria, analysis methods, and more.  Armed with these predictive insights, biopharma has the evidence it needs to move forward knowing every tradeoff has already been tested.

1738155873-screenshot-qh-platform-1

Additional Modules

1738064519-indication-selected-module

Indication Selection

Our AI-based indication selection module predicts the efficacy and safety of drugs across various medical conditions, drawing on the immense variability within, but also across various diseases. By presenting the results in an intuitive and clinically relevant manner, this tool enables precise and efficient decision-making in early clinical development.
1735159112-clinical-development-2 (1)

Target Product Profile

Our AI-based Target Product Profile (TPP) module predicts key TPP parameters, focusing on primary endpoints and safety. This tool enhances strategic decision-making by providing reliable perspective on the therapeutic potential and safety profile of the asset.
1738064519-pts-modules (1)

Probability of Technical Success

By integrating rigorous efficacy and safety simulation with real-world evidence, QuantHealth's probability of technical success module aids in optimizing clinical trial investments, minimizing risk, and enhancing decision-making processes in drug development.
1735159142-clinical-development-4 (1)

Market Forecasting

Predict the expected number of patients in various geographical markets based on a specific cohort definition. This module allows to compare the global patient population across different cohorts, enabling more informed and strategic planning.
1738064519-enrollment-prediction-modules (1)

Enrollment Prediction

The patient recruitment module predicts site-level and global trial enrollment over time by examining the cohort itself as well as hundreds of protocol parameters such as protocol complexity, site burden, estimated site performance, investigator, and more. This module supports site selection, feasibility analysis, and provides an essential operational perspective to any trial design team.

Prospectively Validated

Predicting trial results before readout, without sponsor data, with up to 90% accuracy on the primary endpoint

IMVOKE010:

Randomized phase III study of atezolizumab (atezo) as adjuvant monotherapy after definitive therapy of squamous cell carcinoma of the head and neck (scchn)

  • Simulated Results 1738068291-imvoken010-simulated-results
  • Actual Results 1736961338-imvoke010-2
1

TROPION-Breast01:

A phase III open-label, randomized study of Dato-DXd versus investigator's choice of chemotherapy (ICC) in participants with inoperable or metastatic HR-positive, HER2-negative breast cancer who have been treated with one or two prior lines of systemic chemotherapy

  • Simulated Results 1738068513-tropion-breast01
  • Actual Results 1736962602-tropion-breast01-2
2

ELOQUENT1

Phase III study of lenalidomide and dexamethasone with or without elotuzumab to treat newly diagnosed, previously untreated multiple myeloma

  • Simulated Results 1738068291-eloquent1
  • Actual Results 1736962717-elqquent1-2 (1)
3
For more Evidence

Explore the Power of Clinical Simulation

Book a Meeting